FDA Says Co. Is Trying To Cash In On Meningitis Outbreak

Law360, New York (November 6, 2012, 3:00 PM EST) -- The U.S. Food and Drug Administration on Monday warned a Tennessee company to stop marketing its “LED light therapy products” as a cure for fungal meningitis, saying such claims were unproven and amounted to an attempt to cash in on an outbreak that has so far killed 30 people.

The FDA sent a warning letter to The Avalon Effect Inc. saying that the company's “Quantum Series Personal Wellness Pack” qualifies as a medical device. Because the company never applied to the FDA to market the device...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.